| NCT ID | NCT03450018 |
| Title | A Study of SLC-0111 and Gemcitabine for Metastatic Pancreatic Ductal Cancer in Subjects Positive for CAIX (SLC-0111-17-01) |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | British Columbia Cancer Agency |
| Indications | |
| Therapies | |
| Age Groups: | adult senior |